These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
10. A feminizing adrenocortical carcinoma in the context of a late onset 21-hydroxylase deficiency. Libé R, Arlt W, Louiset E, Waintrop C, Guibourdenche J, Sibony M, Clauser E, Groussin L. J Clin Endocrinol Metab; 2014 Jun 26; 99(6):1943-4. PubMed ID: 24654754 [No Abstract] [Full Text] [Related]
11. [Feminizing adrenocortical tumor]. Horiba N, Nomura K, Demura H. Ryoikibetsu Shokogun Shirizu; 1993 Jun 26; (1):472-4. PubMed ID: 7757646 [No Abstract] [Full Text] [Related]
12. [Malignant tumour of adrenal with feminizing syndrome and primary hyperaldosteronism (author's transl)]. Cathelineau G, Poizat R, Legrand JC, Canivet J. Ann Endocrinol (Paris); 1980 Jun 26; 41(1):65-6. PubMed ID: 7396400 [Abstract] [Full Text] [Related]